FDA Modernization Act 2.0
This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.
The bill also removes a requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2022-09-29 | Floor | Held at the desk. | House floor actions |
| 2022-09-29 | Floor | Received in the House. | House floor actions |
| 2022-09-29 | Floor | Message on Senate action sent to the House. | Senate |
| 2022-09-29 | Floor | Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent. (consideration: CR S5514-5515; text: CR S5514-5515) | Senate |
| 2022-09-29 | IntroReferral | Introduced in Senate | Library of Congress |